Clinical Trials Currently Recruiting Patients

  • Study: HALO-301 PEGPH20 in combination with ABRAXANE® (nab-paclitaxel) and gemcitabine
  • Indication: Metastatic Pancreatic Cancer
  • Phase: Phase 3
  • More Information:
  • Study: HALO-101 PEGPH20 in combination with KEYTRUDA® (pembrolizumab)
  • Indication: Non-Small Cell Lung Cancer and Gastric Cancer
  • Phase: Phase 1
  • More Information:


You are now leaving Halozyme is not responsible for or endorses the content of the linked site.